MODAFOCUS 300
- Active ingredient
- Modafinil
- Dosage
- 300 mg
- Best before date
- Until 2028
- Number of tablets
- 10 pills
- Reception
- 1 pills
- Time of action
- Up to 12 hours
- Daily dose
- 400 mg
- Compatibility with alcohol
- Yes
Available product types:
What is MODAFOCUS 300?
MODAFOCUS 300 is a medicinal product containing the active substance modafinil, belonging to a group of medications that promote wakefulness and reduce excessive daytime sleepiness. It is categorized among other generics, nootropics, and modafinil-based agents, although its primary clinical effect is not "memory improvement," but the regulation of the sleep–wake cycle. The product is available in the form of oral tablets with a dosage of 300 mg. The manufacturer of MODAFOCUS 300 is the pharmaceutical company Fortune Healthcare.
Modafinil affects neurotransmitter systems in the brain — biologically active substances through which nerve cells transmit signals. Owing to this, it can enhance alertness, maintain concentration, and reduce the tendency to fall asleep during the day. Unlike classic psychostimulants, modafinil's mechanism of action is complex and cannot be reduced to the direct stimulation of a single system. The effect and tolerability of MODAFOCUS 300 depend on the underlying cause of sleepiness, concomitant conditions, sleep schedule, and individual bodily response.
The medication is not intended to compensate for chronic sleep deprivation, night work without rest, or fatigue in healthy individuals. MODAFOCUS 300 does not replace full rest, sleep apnea treatment, or lifestyle modifications. Prior to starting the medication, a consultation with a physician is necessary, especially if sleepiness occurred suddenly, is accompanied by fainting, shortness of breath, depression, or other alarming symptoms. A specialist must determine the cause of the wakefulness impairment and assess the appropriateness of therapy.
What is MODAFOCUS 300 prescribed for?
The primary indication for the use of modafinil is excessive daytime sleepiness associated with certain sleep disorders. These include narcolepsy — a neurological condition in which a person may experience overwhelming episodes of falling asleep during the day. The medication can help maintain activity during wakefulness periods, but it does not eliminate all manifestations of narcolepsy and does not replace comprehensive treatment. The therapeutic regimen is determined individually following a medical examination.
MODAFOCUS 300 may also be considered for residual sleepiness in patients with obstructive sleep apnea. This is a disorder in which breathing periodically stops or is significantly limited during sleep due to upper airway obstruction. It is important to understand that modafinil does not treat the underlying cause of apnea and does not replace continuous positive airway pressure (CPAP) therapy if prescribed. Its use is possible only as an additional component under medical supervision.
Another clinical application is sleepiness associated with shift work sleep disorder, where night shifts or frequent work schedule changes disrupt the natural circadian rhythm. In such cases, the drug may be prescribed to maintain alertness during the planned work period. Unsupervised use of MODAFOCUS 300 for studying, exams, prolonged driving, or productivity enhancement is dangerous and does not comply with the principles of safe pharmacotherapy. It is especially important not to mask severe exhaustion and sleep deficit with this medication.
Composition and active ingredients of MODAFOCUS 300
The main active substance of MODAFOCUS 300 is modafinil at a dose of 300 mg per tablet. Modafinil activates wakefulness-promoting mechanisms in the central nervous system and influences, among others, the dopamine, norepinephrine, histamine, and orexin systems. Orexin is a neuropeptide involved in controlling alertness and the stability of the sleep–wake cycle. It is precisely this multi-component effect that explains the drug's ability to reduce sleepiness without being identical in action to traditional stimulants.
The tablets also contain excipients necessary for formulating the dosage form, ensuring product stability, and securing proper release of the active substance. Their precise list may vary depending on the batch and manufacturer specifications, so the patient leaflet inside the package should be reviewed before use. Patients with allergies to dyes, lactose, starch, or other excipients should discuss the composition with a doctor or pharmacist. If a rash, swelling, or itching appears after taking the tablets, discontinue use and seek medical assistance.
Dosage of MODAFOCUS 300
The dosage of MODAFOCUS 300 must be determined by a physician taking into account the diagnosis, age, coexisting diseases, blood pressure, and response to treatment. For modafinil, daily doses in clinical practice often range between 100–200 mg, but in specific situations, a physician may prescribe a different dose in accordance with official instructions and patient needs. The 300 mg tablet is a high-dose form; therefore, it is not suitable for self-adjustment of therapy. Do not divide the tablet or alter the dose without clarifying whether this is provided for by the manufacturer.
For narcolepsy and residual sleepiness associated with sleep apnea, the drug is usually taken in the morning to avoid disrupting nighttime sleep. In shift work sleep disorder, the timing of administration may differ and be tied to the start of the night shift. The duration of the course depends on the cause of sleepiness and the results of regular medical monitoring. If the effect is insufficient or adverse reactions occur, adjustment of the regimen is carried out solely by a specialist.
Patients with impaired liver function, cardiovascular diseases, a history of psychiatric disorders, or elderly individuals may require a more cautious approach and a lower starting dose. Do not exceed the recommended number of tablets in an attempt to achieve a faster effect. Overdose can manifest as insomnia, anxiety, rapid heartbeat, elevated blood pressure, nausea, and agitation. In the event of taking an excessive dose, seek emergency medical care immediately.
How to take MODAFOCUS 300 correctly?
MODAFOCUS 300 is taken orally by swallowing the tablet whole with a sufficient amount of water. The medication can be taken with or without food; however, fatty food may sometimes slightly delay the onset of action. To reduce the risk of insomnia, it is undesirable to take modafinil in the afternoon or evening unless a different schedule was prescribed by a physician. It is recommended to maintain a consistent administration time according to the individual scheme.
If a regular dose is missed, do not take a double dose. A missed dose should only be taken if there is sufficient time remaining before the planned night sleep and this does not contradict medical recommendations. If the day is already approaching evening, it is usually safer to skip the dose and return to the normal schedule the following day. Regularly exceeding the dose does not proportionally increase the therapeutic result, but increases the risk of adverse reactions.
During treatment, night sleep quality, anxiety levels, heart rate, and blood pressure should be monitored, especially in the presence of hypertension. MODAFOCUS 300 does not guarantee full restoration of the ability to safely perform hazardous work if sleepiness persists. Prior to evaluating one's own response, one should refrain from driving vehicles, working at heights, or operating machinery requiring unimpaired concentration. Any changes in well-being must be discussed with a doctor.
Side effects of MODAFOCUS 300
The most common adverse reactions to MODAFOCUS 300 may include headache, nausea, dry mouth, decreased appetite, nervousness, anxiety, and insomnia. Dizziness, abdominal pain, diarrhea or constipation, rapid heartbeat, and increased blood pressure sometimes occur. The severity of symptoms may depend on the dose, time of administration, and individual sensitivity. If side effects do not subside, intensify, or interfere with daily life, medical consultation is required.
Less frequently, mood changes, irritability, depressive thoughts, agitation, confusion, or psychotic symptoms may occur, especially in individuals with a corresponding predisposition or a history of psychiatric disorders. In such situations, self-treatment should not be continued, nor should symptoms be hidden. It is important to inform a specialist about any behavioral changes, unusual aggressiveness, panic attacks, or self-harm thoughts. Treatment adjustment may require dose reduction or discontinuation of the drug.
Signs of a severe allergic reaction require immediate medical attention: widespread rash, blisters, mucosal lesions of the mouth or eyes, facial swelling, difficulty breathing, fever, or swollen lymph nodes. Such reactions are rare, but can be life-threatening. Emergency medical care should also be sought for chest pain, a significant rise in blood pressure, fainting, or marked heart rhythm disturbances. The body's individual response to modafinil can be unpredictable, so the first days of therapy require special alertness.
Contraindications of MODAFOCUS 300
MODAFOCUS 300 is contraindicated in case of known hypersensitivity to modafinil, related substances, or any component of the tablet. The drug should not be used in patients with a history of severe skin reactions to modafinil. Special caution is required in patients with uncontrolled arterial hypertension, arrhythmias, ischemic heart disease, or other significant cardiovascular disorders. Prior to initiating therapy, the physician may recommend assessing blood pressure, heart rate, and cardiac history.
In the presence of depression, bipolar disorder, psychosis, anxiety disorders, or substance dependence, the drug is used only after a careful risk assessment. Modafinil can affect emotional state and, in certain cases, trigger an exacerbation of psychiatric symptoms. In cases of hepatic or renal impairment, individual therapy adjustment may be required. In elderly patients, treatment is usually initiated with particular caution due to possible increased sensitivity to the medication.
During pregnancy, MODAFOCUS 300 is not recommended unless clearly indicated medically, as the safety of modafinil for the fetus has not been adequately confirmed. Women of childbearing potential should discuss reliable methods of contraception with a doctor, as modafinil can reduce the effectiveness of certain hormonal contraceptives. During breastfeeding, the decision regarding treatment is made individually, evaluating the potential risk to the infant. The drug is not used in children and adolescents without a specific medical prescription.
Interaction of MODAFOCUS 300 with other medicines and alcohol
Modafinil can alter the activity of liver enzymes involved in the metabolism of many medicinal products. Because of this, it can affect the efficacy of hormonal contraceptives, anticoagulants, anticonvulsants, certain antidepressants, immunosuppressants, and other medications. Before starting MODAFOCUS 300, inform your physician about all prescription and over-the-counter medicines, vitamins, herbal supplements, and stimulants being used. Unsupervised combination with drugs that increase blood pressure, affect heart rhythm, or stimulate the central nervous system is especially undesirable.
Alcohol can unpredictably alter nervous system reactions, mask fatigue, and increase the risk of dangerous behavior, which is why combining it with MODAFOCUS 300 is not recommended. Even when feeling alert, the ability to assess risks, reaction speed, and sleep quality may deteriorate. At the beginning of treatment, driving vehicles and operating potentially dangerous machinery should be avoided until the individual response of the body becomes clear. If sleepiness does not disappear completely, one must abstain from such activities.
Where to buy MODAFOCUS 300 in Ukraine
MODAFOCUS 300 in Ukraine should be purchased only through legal pharmacy channels that ensure proper storage conditions, control of origin, and the ability to verify package integrity. Before ordering at a pharmacy or via a pharmacy service, it is advisable to check availability, batch, expiration date, and prescription requirements in accordance with applicable dispensing rules. Purchasing modafinil from private sellers or unverified platforms is not recommended due to the risk of acquiring a counterfeit or improperly stored product. The decision to purchase should be made after consultation with a doctor.
Tablets should be stored in their original packaging, in a dry place protected from direct sunlight and out of reach of children. Do not leave the product in the bathroom, car, or near heat sources, as moisture and high temperature can degrade the quality of the medicinal product. Upon delivery, inspect the packaging and do not use tablets with altered color, damaged coating, or an expired shelf life. MODAFOCUS 300 requires responsible use, regular medical supervision, and adherence to the prescribed treatment regimen.








































/tadaflo-5-ukraine-india-127-228x228.jpg)








